<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02532244</url>
  </required_header>
  <id_info>
    <org_study_id>764456</org_study_id>
    <nct_id>NCT02532244</nct_id>
  </id_info>
  <brief_title>Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases</brief_title>
  <official_title>Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nemours Children's Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nemours Children's Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to establish a genetic registry of patients with early-onset motor&#xD;
      neuron and neuromuscular diseases. The investigators will collect samples from patients with&#xD;
      a motor neuron or a neuromuscular disorder and their family members. The samples to be&#xD;
      collected will be obtained using minimally invasive (whole blood) means. The research team&#xD;
      will then extract high quality genomic DNA or RNA from these samples and use it to identify&#xD;
      and confirm novel gene mutations and to identify genes which regulate the severity of motor&#xD;
      neuron/neuromuscular diseases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diseases affecting the motor unit--which is composed of the motor neuron, its myelin sheath&#xD;
      and its innervated muscle fibers--are a diverse, heterogeneous group having heterogeneous&#xD;
      clinical presentations and genetic causes. Many of these disorders have a inherited&#xD;
      component. In some cases, the genetics underlying a given neuromuscular/motor neuron disease,&#xD;
      like spinal muscular atrophy (SMA) or Duchenne muscular dystrophy, are well characterized.&#xD;
      There are, however, disorders whose genetic basis has yet to be determined or genetically&#xD;
      characterized diseases which harbor novel mutations. The purpose of this genetic registry is&#xD;
      to catalogue early-onset motor neuron and neuromuscular disorders and to determine their&#xD;
      genetic bases. With samples obtained from this registry, the investigators will be able to&#xD;
      provide a genetic diagnosis for a specific neuromuscular/motor neuron disease which will lead&#xD;
      to better care for those patients affected by these diseases.&#xD;
&#xD;
      Many of these disorders have a wide spectrum of phenotypic variability. For example, the&#xD;
      severity of SMA is quite variable even though it is caused by the loss of a single gene, i.e.&#xD;
      survival motor neuron 1 (SMN1). The number of copies of the duplicated gene survival motor&#xD;
      neuron 2 (SMN2) dictates phenotypic severity in SMA. In this study, the research team will&#xD;
      also identify potential modifiers of phenotypic severity for specific disorders like SMA and&#xD;
      Charcot-Marie-Tooth (CMT) disease. With the identification of novel modifier genes, the&#xD;
      investigators will be able to more accurately predict disease outcomes and the investigators&#xD;
      will also have novel targets for the development of therapeutic agents for these diseases.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>genetic diagnosis</measure>
    <time_frame>up to 2 years</time_frame>
    <description>The genetic basis for the subject's condition will be verified/determined by Sanger sequencing of DNA sample</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SMN1 copy number</measure>
    <time_frame>up to 2 years</time_frame>
    <description>The number of copies of the SMN1 gene will be determined using array digital polymerase chain reaction (PCR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SMN2 copy number</measure>
    <time_frame>up to 2 years</time_frame>
    <description>The number of copies of the SMN2 gene will be determined using array digital PCR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>target gene mRNA levels</measure>
    <time_frame>up to 2 years</time_frame>
    <description>The relative levels of the disease gene-specific messenger ribonucleic acid (mRNA) will be measured using quantitative PCR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>target gene protein levels</measure>
    <time_frame>up to 2 years</time_frame>
    <description>The relative amounts of the disease-gene-specific protein will be measured using immunoblot.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Spinal Muscular Atrophy</condition>
  <condition>Charcot-Marie-Tooth Disease</condition>
  <condition>Muscular Dystrophy</condition>
  <condition>Spinal Muscular Atrophy With Respiratory Distress 1</condition>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <condition>Motor Neuron Disease</condition>
  <condition>Neuromuscular Disease</condition>
  <condition>Peroneal Muscular Atrophy</condition>
  <arm_group>
    <arm_group_label>sample collection</arm_group_label>
    <description>Each participant will have blood drawn for genetic analysis and for establishment of a lymphoblastoid cell line.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sample collection</intervention_name>
    <description>collection of blood</description>
    <arm_group_label>sample collection</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, lymphoblastoid cell lines derived from peripheral blood mononuclear cells, saliva,&#xD;
      buccal cells&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study will enroll children diagnosed with a motor neuron or neuromuscular disease as&#xD;
        well as their parents and/or siblings as well as adults with childhood-onset motor neuron&#xD;
        or neuromuscular diseases.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of motor neuron/neuromuscular disease confirmed by neurologist&#xD;
&#xD;
          -  Be seen by one of the study investigators&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  not seen by one of the study investigators&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew ER Butchbach, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nemours Children's Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthew ER Butchbach, Ph.D.</last_name>
    <phone>302-298-7366</phone>
    <email>Matthew.Butchbach@nemours.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kimberly Klipner, M.S.</last_name>
    <phone>302-651-4088</phone>
    <email>Kimberly.Klipner@nemours.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alfred I. duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew ER Butchbach, Ph.D.</last_name>
      <phone>302-298-7366</phone>
      <email>Matthew.Butchbach@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Mena Scavina, D.O.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Mackenzie, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Heinle, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Howard, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Specialty Care</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew ER Butchbach, Ph.D.</last_name>
      <phone>302-298-7266</phone>
      <email>Matthew.Butchbach@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Jun Ho Kim, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew ER Butchbach, Ph.D.</last_name>
      <phone>302-298-7366</phone>
      <email>Matthew.Butchbach@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Midvis Monduy, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Stabley DL, Holbrook J, Harris AW, Swoboda KJ, Crawford TO, Sol-Church K, Butchbach MER. Establishing a reference dataset for the authentication of spinal muscular atrophy cell lines using STR profiling and digital PCR. Neuromuscul Disord. 2017 May;27(5):439-446. doi: 10.1016/j.nmd.2017.02.002. Epub 2017 Feb 6.</citation>
    <PMID>28284873</PMID>
  </results_reference>
  <results_reference>
    <citation>Stabley DL, Harris AW, Holbrook J, Chubbs NJ, Lozo KW, Crawford TO, Swoboda KJ, Funanage VL, Wang W, Mackenzie W, Scavina M, Sol-Church K, Butchbach ME. SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR. Mol Genet Genomic Med. 2015 Jul;3(4):248-57. doi: 10.1002/mgg3.141. Epub 2015 Mar 21.</citation>
    <PMID>26247043</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen X, Sanchis-Juan A, French CE, Connell AJ, Delon I, Kingsbury Z, Chawla A, Halpern AL, Taft RJ; NIHR BioResource, Bentley DR, Butchbach MER, Raymond FL, Eberle MA. Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data. Genet Med. 2020 May;22(5):945-953. doi: 10.1038/s41436-020-0754-0. Epub 2020 Feb 18.</citation>
    <PMID>32066871</PMID>
  </results_reference>
  <results_reference>
    <citation>Jiang L, Lin R, Gallagher S, Zayac A, Butchbach MER, Hung P. Development and validation of a 4-color multiplexing spinal muscular atrophy (SMA) genotyping assay on a novel integrated digital PCR instrument. Sci Rep. 2020 Nov 16;10(1):19892. doi: 10.1038/s41598-020-76893-7.</citation>
    <PMID>33199817</PMID>
  </results_reference>
  <results_reference>
    <citation>Stabley DL, Holbrook J, Scavina M, Crawford TO, Swoboda KJ, Robbins KM, Butchbach MER. Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR. Neurogenetics. 2021 Mar;22(1):53-64. doi: 10.1007/s10048-020-00630-5. Epub 2021 Jan 7.</citation>
    <PMID>33415588</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 21, 2015</study_first_submitted>
  <study_first_submitted_qc>August 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2015</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nemours Children's Clinic</investigator_affiliation>
    <investigator_full_name>Matthew E. R. Butchbach, Ph.D.</investigator_full_name>
    <investigator_title>Research Scientist</investigator_title>
  </responsible_party>
  <keyword>distal hereditary motor neuronopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Tooth Diseases</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy, Spinal</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Charcot-Marie-Tooth Disease</mesh_term>
    <mesh_term>Nerve Compression Syndromes</mesh_term>
    <mesh_term>Hereditary Sensory and Motor Neuropathy</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>De-identified information will be shared once the data are published.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

